Market Value2,229,435,000
Total Holdings64
File Date2015-02-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ICPT / Intercept Pharmaceuticals Inc
GEVA / Synageva Biopharma Corp
AKRX / Akorn, Inc.
SGEN / Seagen Inc
RLYP / Relypsa, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
ANTH / Anthera Pharmaceuticals, Inc.
XLRN / Acceleron Pharma Inc
AMPH / Amphastar Pharmaceuticals, Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
SHPG / Shire Plc.
HTWR / Heartware International Inc.
CLVS / Clovis Oncology Inc
US60877T1007 / Momenta Pharmaceuticals, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
ZSPH / ZS Pharma, Inc.
02318X100 / Ambit Biosciences Corp
RNA / Avidity Biosciences, Inc.
PRQR / ProQR Therapeutics N.V.
IMDZ / Immune Design Corp.
WMGIZ / Wright Medical Group N.V.
MDVN / Medivation, Inc.
INVA / Innoviva, Inc.
NPSP / NPS Pharmaceuticals Inc
91911K102 / Bausch Health Companies
WX / Wuxi Pharmatech (Cayman) Inc.
KERX / Keryx Biopharmaceuticals, Inc.
G0083B108 / Actavis
INGN / Inogen, Inc.
COV /
US00448Q2012 / Achillion Pharmaceuticals, Inc.
OMED / OptMed Inc
KPTI / Karyopharm Therapeutics Inc.
SESN / Sesen Bio Inc.
CELG / Celgene Corp.
UHS / Universal Health Services, Inc.
ADXS / Ayala Pharmaceuticals, Inc.
PRGO / Perrigo Company plc
HCA / HCA Healthcare, Inc.
ABT / Abbott Laboratories
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
018490100 / Allergan plc
0PP / Portola Pharmaceuticals Inc
CMRX / Chimerix, Inc.
IMGN / ImmunoGen, Inc.
US00C4U1L353 / Mylan N.V.
ALGN / Align Technology, Inc.
ABBV / AbbVie Inc.
MNKKQ / Mallinckrodt Plc
NXTM / NxStage Medical, Inc.
CI / The Cigna Group
QURE / uniQure N.V.
TNDM / Tandem Diabetes Care, Inc.
ARAY / Accuray Incorporated
CBAY / CymaBay Therapeutics, Inc.
GILD / Gilead Sciences, Inc.
SGNT / Sagent Pharmaceuticals, Inc.
BMRN / BioMarin Pharmaceutical Inc.
BIIB / Biogen Inc.
MDT / Medtronic plc
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
BSX / Boston Scientific Corporation
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
TMO / Thermo Fisher Scientific Inc.
UTHR / United Therapeutics Corporation
DXCM / DexCom, Inc.
INCY / Incyte Corporation
HALO / Halozyme Therapeutics, Inc.
PFE / Pfizer Inc.
ISRG / Intuitive Surgical, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
INSM / Insmed Incorporated
AMGN / Amgen Inc.
PTCT / PTC Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
VRTX / Vertex Pharmaceuticals Incorporated